Springer

Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 November 2004, Vol. 104, No. 9, pp. 2616-2617.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bessler, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bessler, M.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow


InsideBlood

HEMOSTASIS

Comment on Ingram et al, page 2752

Endothelial progenitor cells: reporting for duty

Monica Bessler

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

Clonogenic assays define a new hierarchy among endothelial progenitor cells.

The classical view of stem cell differentiation is a hierarchical model that starts with a primitive stem cell at the top, giving rise to a proliferating progenitor pool from which differentiated blood cells develop. As the progeny of stem cells acquire more specific differentiated characteristics they lose their potential to proliferate. The ability for continuous self-renewal is characteristic of the most primitive stem cells. This ability is lost with advancing differentiation. Hematopoiesis is usually seen as a classical example of hierarchical stem cell differentiation and there are many experimental data that support such a hierarchical model.1-4 A more recent model of stem cell plasticity challenges the classical rigid archetype of hierarchical stem cell differentiation, suggesting that the stem cell, progenitor, and differentiated mature cell relationship is not a fixed hierarchy but rather a reversible continuum (reviewed in Balsam et al5).Go



Hierarchy of hematopoietic/endothelial stem cell differentiation. The model proposed by Ingram and colleagues implies that endothelial cell differentiation is hierarchical in nature and similar to the differentiation model of the myeloid and lymphoid lineage. The existence of a common progenitor cell that gives rise to both endothelial cells and hematopoietic cells in the adult human bone marrow is of great interest but still remains controversial. The curved arrow indicates self-renewing ability. HSC indicates hematopoietic stem cell; CFU-GEMM, colony-forming unit granulocyte erythrocyte monocyte macrophage; BFU-E, erythroid burst-forming unit; BFU-MK, megakaryocyte burst-forming unit; CFU-GM, granulocyte macrophage colony-forming unit; CFU-G; granulocyte colony-forming unit; CFU-E, erythroid cluster-forming unit; CFU-Eo, eosinophil colony-forming unit; CFU-Baso; basophil colony-forming unit; CFU-Mast; mast cell colony-forming unit; HPP-ECFC, high proliferative potential-endothelial colony-forming cells; LPP-ECFC, low proliferative potential-endothelial colony-forming cells; and EC-cluster, endothelial cell cluster.

 

In this issue of Blood, Ingram and colleagues use a single-cell colony assay to describe a novel hierarchy amongst human endothelial progenitor cells (EPCs) isolated from peripheral blood and umbilical cord. The identification of a distinct population of progenitor cells is based on their clonogenic and proliferative potential. High-proliferative potential-endothelial colony-forming cells (HPP-ECFCs) are large colonies that form secondary and tertiary colonies upon replating. HPP-ECFCs give rise to all subsequent stages of EPCs to secondary HPP-ECFCs. Low-proliferative potential-endothelial colony-forming cells (LPP-ECFCs) form colonies of more than 50 cells but no secondary LPP-ECFCs upon relating. Endothelial cell clusters (EC clusters) contain fewer than 50 cells and show recognizable features of differentiation; finally, the mature endothelial cells do not divide (Figures 1 and 7 in the paper by Ingram and colleagues in this issue of Blood). There has been a multitude of prior studies that describe the isolation of EPCs from human peripheral blood or umbilical cord. However, many of these so-called EPCs, although expressing some of the markers shared by both hematopoietic cells and EPCs, contained CD14+ cells that maintain the expression of the hematopoietic surface antigen CD45. Although these cells seem to support angiogenesis in vivo, this seemed to occur through the secretion of factors promoting angiogenesis rather than through proliferation and contribution to the lining of the neovasculature. Thus, these cells seemed more like circulating angiogenic cells than EPCs.6 The endothelial cells that outgrow from the progenitor cells isolated by the method described by Ingram and colleagues showed phenotypic and functional characteristics of endothelial cells and lack hematopoietic characteristics such as CD45 and CD14. Genetic studies in mice clearly demonstrate that during embryogenesis, and probably also in the adult bone marrow, mature blood cells and EPCs have a common progenitor cell, the hemangioblast (reviewed in Bailey and Flemming7). So far, compelling evidence that such a cell exists in humans is missing and awaits future rigorous genetic and/or functional studies. The existence of such a progenitor cell in adults would be a missing piece in the jigsaw of hematopoiesis and would have all kinds of implications for developing therapy. The ability to isolate and precisely assay EPCs is an important step and will stimulate future research to explore the use of endothelial cells as novel targets for diagnostic and therapeutic agents.

Acknowledgements

I thank Philip J. Mason and Dan C. Link for interesting discussions.

References

  1. Smith LG, Weissman IL, Heimfeld S. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci U S A. 1991;88: 2788-2792.[Abstract/Free Full Text]

  2. Guenechea G, Gan OI, Dorrell C, Dick JE. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol. 2001;2: 75-82.[CrossRef][Medline] [Order article via Infotrieve]

  3. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404: 193-197.[CrossRef][Medline] [Order article via Infotrieve]

  4. Borge OJ, Adolfsson J, Jacobsen AM. Lymphoid-restricted development from multipotent candidate murine stem cells: distinct and complimentary functions of the c-kit and flt3-ligands. Blood. 1999;94: 3781-3790.[Abstract/Free Full Text]

  5. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004;428: 668-673.[CrossRef][Medline] [Order article via Infotrieve]

  6. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation. 2003;107: 1164-1169.[CrossRef][Medline] [Order article via Infotrieve]

  7. Bailey AS, Fleming WH. Converging roads: evidence for an adult hemangioblast. Exp Hematol. 2003;31: 987-993.[Medline] [Order article via Infotrieve]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood
David A. Ingram, Laura E. Mead, Hiromi Tanaka, Virginia Meade, Amy Fenoglio, Kelly Mortell, Karen Pollok, Michael J. Ferkowicz, David Gilley, and Mervin C. Yoder
Blood 2004 104: 2752-2760. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bessler, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bessler, M.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020